ProfileGDS4718 / 207036_x_at
TitleColorectal cancer: homogenized tumor tissues
OrganismHomo sapiens


no metastasis metastatic recurrence metastasis stage: 0 stage: 1 stage: 2a stage: 2b stage: 3b stage: 3c stage: 2a stage: 2b stage: 3b stage: 3c stage: 4 GSM549121 GSM549102 GSM549104 GSM549108 GSM549119 GSM549133 GSM549139 GSM549099 GSM549109 GSM549110 GSM549114 GSM549122 GSM549134 GSM549136 GSM549140 GSM549111 GSM549113 GSM549132 GSM549137 GSM549142 GSM549100 GSM549107 GSM549115 GSM549116 GSM549120 GSM549131 GSM549118 GSM549129 GSM549123 GSM549124 GSM549126 GSM549128 GSM549103 GSM549117 GSM549138 GSM549141 GSM549130 GSM549101 GSM549105 GSM549106 GSM549112 GSM549125 GSM549127 GSM549135 38% 43% 35% 45% 27% 35% 23% 55% 43% 41% 43% 24% 32% 26% 31% 43% 37% 29% 28% 28% 53% 36% 41% 40% 35% 26% 30% 25% 32% 32% 28% 25% 43% 39% 36% 28% 27% 47% 45% 38% 36% 27% 29% 25% sort by disease state sort by other Gene Expression Profile
Graph caption help
SampleTitleValueRank
GSM549121patient 080, normal, homogenized [OPG study]4.9157938
GSM549102patient 115, normal, homogenized [OPG study]5.1806843
GSM549104patient 119, normal, homogenized [OPG study]4.7663335
GSM549108patient 138, normal, homogenized [OPG study]5.3083645
GSM549119patient 077, normal, homogenized [OPG study]4.4343827
GSM549133patient 032, cancer, homogenized [OPG study]4.7053335
GSM549139patient 042, cancer, homogenized [OPG study]4.2344323
GSM549099patient 107, normal, homogenized [OPG study]5.8025955
GSM549109patient 139, normal, homogenized [OPG study]5.142543
GSM549110patient 046, normal, homogenized [OPG study]5.0672641
GSM549114patient 063, normal, homogenized [OPG study]5.1025643
GSM549122patient 082, normal, homogenized [OPG study]4.3127424
GSM549134patient 033, cancer, homogenized [OPG study]4.6246932
GSM549136patient 036, cancer, homogenized [OPG study]4.2992626
GSM549140patient 044, cancer, homogenized [OPG study]4.5565131
GSM549111patient 047, normal, homogenized [OPG study]5.1406143
GSM549113patient 057, normal, homogenized [OPG study]4.7992137
GSM549132patient 031, cancer, homogenized [OPG study]4.4852529
GSM549137patient 038, cancer, homogenized [OPG study]4.4538128
GSM549142patient 047, cancer, homogenized [OPG study]4.5650128
GSM549100patient 110, normal, homogenized [OPG study]5.6877153
GSM549107patient 135, normal, homogenized [OPG study]4.7783936
GSM549115patient 068, normal, homogenized [OPG study]4.9900741
GSM549116patient 072, normal, homogenized [OPG study]4.9729540
GSM549120patient 078, normal, homogenized [OPG study]4.7502635
GSM549131patient 030, cancer, homogenized [OPG study]4.3216826
GSM549118patient 074, normal, homogenized [OPG study]4.5572130
GSM549129patient 027, cancer, homogenized [OPG study]4.3367525
GSM549123patient 088, normal, homogenized [OPG study]4.6249432
GSM549124patient 006, cancer, homogenized [OPG study]4.6773132
GSM549126patient 015, cancer, homogenized [OPG study]4.4324728
GSM549128patient 025, cancer, homogenized [OPG study]4.3120425
GSM549103patient 117, normal, homogenized [OPG study]5.1946943
GSM549117patient 073, normal, homogenized [OPG study]4.9023639
GSM549138patient 041, cancer, homogenized [OPG study]4.7667136
GSM549141patient 045, cancer, homogenized [OPG study]4.3826328
GSM549130patient 028, cancer, homogenized [OPG study]4.4224427
GSM549101patient 111, normal, homogenized [OPG study]5.359347
GSM549105patient 128, normal, homogenized [OPG study]5.2397245
GSM549106patient 134, normal, homogenized [OPG study]4.8710438
GSM549112patient 048, normal, homogenized [OPG study]4.8050636
GSM549125patient 011, cancer, homogenized [OPG study]4.424527
GSM549127patient 024, cancer, homogenized [OPG study]4.4625329
GSM549135patient 035, cancer, homogenized [OPG study]4.2949725